Science
Will a TB vaccine achieve phase 3 clinical trial success by January 31, 2027?
Ends 31 January 2027 · 137 days left · ₦62.1M volume
⚠️ Warning: Insider trading is not permitted. Do not trade on non-public information.
YES contract price
₦5516₦ this month
₦62.1M volume
3,678 traders · 137 days left
Order book — YES
Sell orders (asks)
- ₦607,388
- ₦591,596
- ₦584,474
- ₦572,181
- ₦562,694
Buy orders (bids)
- ₦543,128
- ₦534,927
- ₦529,414
- ₦514,742
- ₦506,160
About this market
Vaccine Development: TB prevention. Multiple TB vaccine candidates in late-stage development.
Resolution rules
Resolves YES if phase 3 trial meets efficacy endpoints (>50% protection), or NO if fails.
Place an order
- Price per contract
- ₦55
- Exchange fee (2%)
- ₦100
- Contracts
- 89.09
- Potential payout
- ₦8,909
- Profit if yes wins
- +₦3,909
Demo trading with virtual naira. Contracts settle at ₦100 if correct, ₦0 if not. Not financial advice — 18+ only.
Exact Score
Predict the exact final score. Click a cell to select, then buy a contract.
₦62.1M traded·3,678 traders
0
1
2
3
4
5
6
7
8
9
10
0
1
2
3
4
5
6
7
8
9
10
Home (left/rows) vs Away (top/columns)